AANA February 2026 Journal Course: Optimizing Buprenorphine Induction: Updated Approaches in Opioid Use Disorder Management

Catalog

Create Account

Availability

On-Demand

Expires on Feb 02, 2027

Cost

Member: $0.00

Non-Member: $50.00

Resident Member: $0.00

Credit Offered

1 MAC Ed Credit

1 Pharmacology Credit

This journal course reviews updated, evidence-based approaches to initiating buprenorphine for the management of opioid use disorder (OUD). Learners will explore buprenorphine’s unique pharmacologic profile, compare traditional induction with newer microdosing and bridging strategies, and examine regulatory, clinical, and practical considerations for implementation. Emphasis is placed on minimizing withdrawal, improving patient comfort, and supporting safer, more effective transitions from full opioid agonists to buprenorphine in diverse clinical settings.

Learning Outcomes:

Describe buprenorphine’s unique pharmacologic profile and safety features that distinguish it from traditional opioid agonists.
Compare and contrast microdosing and bridging strategies for buprenorphine initiation.
Identify regulatory requirements, clinical considerations and implementation challenges for initiating buprenorphine in opioid-dependent patients.

This program has been prior approved by the American Association of Nurse Anesthesiology for 1.00 MAC Ed CE credits; Code Number 1046507; Expiration Date 2/2/2027.

The American Association of Nurse Anesthesiology designates this program as meeting the criteria for up to 1.00 CE credits in Pharmacology & Therapeutics.

Michelle Canale, DNP, CRNA
Hannah Messenger, BSN, RN
Ruchama Barkai, DNP, CRNA
Marleny Estevez, DNP, CRNA
Jennifer Louis, DNP, CRNA
Sarah Jingying Zhang, PhD, CRNA

None of the content experts for this activity have relevant financial relationship(s) to disclose with ineligible companies.

Accreditation Information:
The American Association of Nurse Anesthesiology is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

AANA is an approved provider by the California Board of Registered Nursing, CEP #10862.

Disclosure Statement:
Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content will be identified by the Nurse Planner within the activity. Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content has been mitigated.

Post-Test Attempt Notice:
A minimum passing score of 80% is required to pass this course. You have TWO opportunities to achieve a passing score. If you fail to achieve a passing score of 80%, you will not receive CE credit for this course.

Content Disclaimer:
The views, information, or opinions expressed within the videos and audio are solely those of the individuals involved and do not necessarily represent those of the American Association of Nurse Anesthesiology.

Course content has been prepared by the presenter/developer, and each viewer agrees that the presenter/developer is solely responsible for the content and the accuracy thereof. The viewer agrees that the American Association of Nurse Anesthesiology has no responsibility or liability for the accuracy or completeness of the content.

Refund Policy:
Continuing education activities are nonrefundable.